Understanding the Spike Protein in COVID-19 Vaccine in Recombinant Vesicular Stomatitis Virus (rVSV) Using Automated Capillary Western Blots

[Image: see text] Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the viral agent that is responsible for the coronavirus disease-2019 (COVID-19) pandemic. One of the live virus vaccine candidates Merck and Co., Inc. was developing to help combat the pandemic was V590. V590 was a liv...

Descripción completa

Detalles Bibliográficos
Autores principales: Gillespie, Paul F., Wang, Yanjie, Hofmann, Carl, Kuczynski, Laura E., Winters, Michael A., Teyral, Jennifer L., Tubbs, Christopher M., Shiflett, Kelsey, Patel, Nisarg, Rustandi, Richard R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843631/
https://www.ncbi.nlm.nih.gov/pubmed/36685032
http://dx.doi.org/10.1021/acsomega.2c06937

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843631/
https://www.ncbi.nlm.nih.gov/pubmed/36685032
http://dx.doi.org/10.1021/acsomega.2c06937

Ejemplares similares